Marilyn Foreman is a Respiratory physician. OpenAlex indexes 165 publications with 7,024 citations (h-index 46).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4441 Atlanta Rd SE Ste 217
Smyrna, GA 30080
Telephone
770-422-1372Provider last certified this registry record 23 Jun 2021.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20253 payments
- Tempus AI, IncProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
88.7%Corticosteroid53.4%Symbicort43%Trelegy Ellipta29%Fluticasone Propionate15%Budesonide-Formoterol Fumarate13%Part D<11 patientsbeta2-Adrenergic Agonist21.4%Albuterol Sulfate Hfa100%Part D≥22 patients+ 1 more class in this area
Anti-infectives
6.7%Macrolide Antimicrobial6.7%Azithromycin100%Part D<11 patientsMetabolism & gastrointestinal
4.6%Corticosteroid4.6%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2007–2012 per NIH RePORTER. The latest:
- Genetic Analysis of Susceptibility to COPD Exacerbations
Morehouse School of Medicine
FY2012$142,045K01HL092601 - NICOTINE METABOLISM IN AFRICAN AMERICAN SMOKERS
Morehouse School of Medicine
FY2011$166,292U54RR026137
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population
Proceedings of the National Academy of Sciences
2020 - COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”